Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a ...

A new study published in the Journal of the American Medical Association showed that low-level blood lead levels in childhood ...

Weill Cornell Medicine investigators have "reverse engineered" ketamine's antidepressant effects to identify potential new ...

New research highlights the growing evidence that cardiovascular fitness and adaptive cognitive training can benefit brain health, potentially lowering risks of dementia, depression, and other ...

For little kids, sugary treats might fuel tantrums while fruit-and-vegetable lovers stay calmer. New Norwegian research ...

Johnson & Johnson today announced findings from the first network meta-analysis (NMA) comparing CAPLYTA® (lumateperone) to FDA-approved atypical antipsychotics for add-on treatment of major depressive ...

People taking semaglutide, the active ingredient in Ozempic and Wegovy, were 44% less likely to be treated for depression and ...

The standard explanation for this is that we are enjoying food so much that we’re consuming far more of it than our bodies ...

Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. Baron Health Care Fund (the ...

AbbVie ABBV stock has risen around 5% since it announced robust first-quarter 2026 results on April 29. It beat estimates for ...

As Nigeria marks the Mental Health Awareness Month this May, there is a growing but under-acknowledged crisis. As far back as 2018, an estimated 14.3 million Nigerians between the ages of 15 and 64 ...

Therapy works wonders for your mental health - if the counselor is good at their job. Fire anyone who shows these warning ...